Cargando…
18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis
BACKGROUND: 18-Fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography ((18)F-FDG PET/CT) scan is useful for diagnosis of osteoarticular infections. Whether (18)F-FDG PET/CT scanning may be used for therapeutic monitoring is not clear. The objective of this study was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550045/ https://www.ncbi.nlm.nih.gov/pubmed/26306506 http://dx.doi.org/10.1186/s13018-015-0274-9 |
_version_ | 1782387400797847552 |
---|---|
author | Chatziioannou, Sofia Papamichos, Odysseas Gamaletsou, Maria N. Georgakopoulos, Alexandros Kostomitsopoulos, Nikolaos G. Tseleni-Balafouta, Sofia Papaparaskevas, Joseph Walsh, Thomas J. Pneumaticos, Spiros G. Sipsas, Nikolaos V. |
author_facet | Chatziioannou, Sofia Papamichos, Odysseas Gamaletsou, Maria N. Georgakopoulos, Alexandros Kostomitsopoulos, Nikolaos G. Tseleni-Balafouta, Sofia Papaparaskevas, Joseph Walsh, Thomas J. Pneumaticos, Spiros G. Sipsas, Nikolaos V. |
author_sort | Chatziioannou, Sofia |
collection | PubMed |
description | BACKGROUND: 18-Fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography ((18)F-FDG PET/CT) scan is useful for diagnosis of osteoarticular infections. Whether (18)F-FDG PET/CT scanning may be used for therapeutic monitoring is not clear. The objective of this study was to develop (18)F-FDG PET/CT scanning for monitoring therapeutic response to antimicrobials in experimental Staphylococcus aureus osteomyelitis. METHODS: A total of 22 rabbits were studied. In 20 animals, the right tibia was inoculated intraoperatively with S. aureus. Two control animals were inoculated with normal saline. A needle was placed in the tibia as a foreign body. Infection was allowed to develop for 21 days when (18)F-FDG PET/CT was performed, the needle was removed, and bone specimens were cultured to confirm infection. Antimicrobial therapy with daptomycin was initiated in all successfully infected animals for 1, 3, or 6 weeks. Following completion of treatment, a second (18)F-FDG PET/CT was performed, animals were euthanized, and infected tibias were harvested for quantitative cultures and histology. A positive scan was defined as (18)F-FDG signal activity greater in the infected tibia than that of the contralateral non-infected control tibia. Therapeutic response was measured by the change of (18)F-FDG signal activity in the infected tibia. RESULTS: All successfully infected animals (n = 14), with microbiologically and/or histologically confirmed osteomyelitis, had positive (18)F-FDG PET/CT scans, while the two control animals had negative scans despite the presence of the foreign body [mean maximum standardized uptake value (SUVmax) (±SD) values 2.96 (±0.80) vs. 1 (±1.10), respectively, P = 0.04]. In the 14 successfully infected animals, the mean SUVmax was significantly higher in the infected compared to the uninfected tibia (P < 0.0001). A SUVmax of 1.4, when used as a cutoff for infection, yielded a diagnostic accuracy of 93 %. At the end of treatment, successfully treated animals and saline controls had a negative (18)F-FDG PET/CT scan (n = 4), while animals with persistent infection despite treatment (n = 12) had a positive (18)F-FDG PET/CT scan (SUVmax 1.0–3.0) (p < 0.001). SUVmax values were significantly reduced after 42 days of treatment from 3.15 ± 0.5 (day 7) to 1.71 ± 0.37 (day 42) (p = 0.05). CONCLUSIONS: (18)F-FDG PET/CT scan is a sensitive and specific tool in therapeutic monitoring of experimental foreign-body osteomyelitis. |
format | Online Article Text |
id | pubmed-4550045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45500452015-08-27 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis Chatziioannou, Sofia Papamichos, Odysseas Gamaletsou, Maria N. Georgakopoulos, Alexandros Kostomitsopoulos, Nikolaos G. Tseleni-Balafouta, Sofia Papaparaskevas, Joseph Walsh, Thomas J. Pneumaticos, Spiros G. Sipsas, Nikolaos V. J Orthop Surg Res Research Article BACKGROUND: 18-Fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography ((18)F-FDG PET/CT) scan is useful for diagnosis of osteoarticular infections. Whether (18)F-FDG PET/CT scanning may be used for therapeutic monitoring is not clear. The objective of this study was to develop (18)F-FDG PET/CT scanning for monitoring therapeutic response to antimicrobials in experimental Staphylococcus aureus osteomyelitis. METHODS: A total of 22 rabbits were studied. In 20 animals, the right tibia was inoculated intraoperatively with S. aureus. Two control animals were inoculated with normal saline. A needle was placed in the tibia as a foreign body. Infection was allowed to develop for 21 days when (18)F-FDG PET/CT was performed, the needle was removed, and bone specimens were cultured to confirm infection. Antimicrobial therapy with daptomycin was initiated in all successfully infected animals for 1, 3, or 6 weeks. Following completion of treatment, a second (18)F-FDG PET/CT was performed, animals were euthanized, and infected tibias were harvested for quantitative cultures and histology. A positive scan was defined as (18)F-FDG signal activity greater in the infected tibia than that of the contralateral non-infected control tibia. Therapeutic response was measured by the change of (18)F-FDG signal activity in the infected tibia. RESULTS: All successfully infected animals (n = 14), with microbiologically and/or histologically confirmed osteomyelitis, had positive (18)F-FDG PET/CT scans, while the two control animals had negative scans despite the presence of the foreign body [mean maximum standardized uptake value (SUVmax) (±SD) values 2.96 (±0.80) vs. 1 (±1.10), respectively, P = 0.04]. In the 14 successfully infected animals, the mean SUVmax was significantly higher in the infected compared to the uninfected tibia (P < 0.0001). A SUVmax of 1.4, when used as a cutoff for infection, yielded a diagnostic accuracy of 93 %. At the end of treatment, successfully treated animals and saline controls had a negative (18)F-FDG PET/CT scan (n = 4), while animals with persistent infection despite treatment (n = 12) had a positive (18)F-FDG PET/CT scan (SUVmax 1.0–3.0) (p < 0.001). SUVmax values were significantly reduced after 42 days of treatment from 3.15 ± 0.5 (day 7) to 1.71 ± 0.37 (day 42) (p = 0.05). CONCLUSIONS: (18)F-FDG PET/CT scan is a sensitive and specific tool in therapeutic monitoring of experimental foreign-body osteomyelitis. BioMed Central 2015-08-27 /pmc/articles/PMC4550045/ /pubmed/26306506 http://dx.doi.org/10.1186/s13018-015-0274-9 Text en © Chatziioannou et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chatziioannou, Sofia Papamichos, Odysseas Gamaletsou, Maria N. Georgakopoulos, Alexandros Kostomitsopoulos, Nikolaos G. Tseleni-Balafouta, Sofia Papaparaskevas, Joseph Walsh, Thomas J. Pneumaticos, Spiros G. Sipsas, Nikolaos V. 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title | 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title_full | 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title_fullStr | 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title_full_unstemmed | 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title_short | 18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis |
title_sort | 18-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental staphylococcus aureus foreign-body osteomyelitis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550045/ https://www.ncbi.nlm.nih.gov/pubmed/26306506 http://dx.doi.org/10.1186/s13018-015-0274-9 |
work_keys_str_mv | AT chatziioannousofia 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT papamichosodysseas 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT gamaletsoumarian 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT georgakopoulosalexandros 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT kostomitsopoulosnikolaosg 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT tselenibalafoutasofia 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT papaparaskevasjoseph 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT walshthomasj 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT pneumaticosspirosg 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis AT sipsasnikolaosv 18fluoro2deoxydglucosepositronemissiontomographycomputedtomographyscanformonitoringthetherapeuticresponseinexperimentalstaphylococcusaureusforeignbodyosteomyelitis |